News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Deals
Inflazyme Pharmaceuticals Ltd. Reviews Its Options After Merger with Z-Tech Falls Apart
April 14, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
VANCOUVER - Inflazyme Pharmaceuticals Ltd. (NEX:IZP.H) said Monday its proposed merger with Z-Tech will not go forward.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
MORE ON THIS TOPIC
Deals
AbbVie bets up to $1.47B for Nxera’s discarded IBD program
November 4, 2026
·
2 min read
·
Gabrielle Masson
Manufacturing
Lonza agrees to buy 5 Merck KGaA facilities to accelerate US expansion
November 3, 2026
·
2 min read
·
Nick Paul Taylor
Deals
Novartis puts $772M BioArctic deal on ice, skates away from brain-delivery alliance
November 3, 2026
·
1 min read
·
Gabrielle Masson
Business
Karyopharm files for bankruptcy, looks to merger with Ayrmid for life raft
November 2, 2026
·
3 min read
·
Angela Gabriel
